questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Caractéristiques de la maladie
Maladies transmissibles
Maladies transmissibles : Questions médicales fréquentes
Diagnostic
5
Grippe
Diagnostic médical
Tuberculose
Diagnostic médical
Hépatite
Tests de dépistage
COVID-19
Diagnostic médical
Traitements
5
VIH
Traitement antirétroviral
Hépatite C
Traitement antiviral
Complications
5
Tuberculose
Complications
Facteurs de risque
5
Tuberculose
Facteurs de risque
Grippe
Facteurs de risque
Hépatite
Facteurs de risque
COVID-19
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladies transmissibles : Questions médicales les plus fréquentes",
"headline": "Maladies transmissibles : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladies transmissibles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-04",
"dateModified": "2026-07-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladies transmissibles"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Caractéristiques de la maladie",
"url": "https://questionsmedicales.fr/mesh/D020969",
"about": {
"@type": "MedicalCondition",
"name": "Caractéristiques de la maladie",
"code": {
"@type": "MedicalCode",
"code": "D020969",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Infections transmissibles par le sang",
"alternateName": "Blood-Borne Infections",
"url": "https://questionsmedicales.fr/mesh/D000086982",
"about": {
"@type": "MedicalCondition",
"name": "Infections transmissibles par le sang",
"code": {
"@type": "MedicalCode",
"code": "D000086982",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.531.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladies transmissibles émergentes",
"alternateName": "Communicable Diseases, Emerging",
"url": "https://questionsmedicales.fr/mesh/D021821",
"about": {
"@type": "MedicalCondition",
"name": "Maladies transmissibles émergentes",
"code": {
"@type": "MedicalCode",
"code": "D021821",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.531.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladies transmissibles importées",
"alternateName": "Communicable Diseases, Imported",
"url": "https://questionsmedicales.fr/mesh/D000076263",
"about": {
"@type": "MedicalCondition",
"name": "Maladies transmissibles importées",
"code": {
"@type": "MedicalCode",
"code": "D000076263",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.531.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladies sexuellement transmissibles",
"alternateName": "Sexually Transmitted Diseases",
"url": "https://questionsmedicales.fr/mesh/D012749",
"about": {
"@type": "MedicalCondition",
"name": "Maladies sexuellement transmissibles",
"code": {
"@type": "MedicalCode",
"code": "D012749",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.531.937"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladies sexuellement transmissibles bactériennes",
"alternateName": "Sexually Transmitted Diseases, Bacterial",
"url": "https://questionsmedicales.fr/mesh/D015231",
"about": {
"@type": "MedicalCondition",
"name": "Maladies sexuellement transmissibles bactériennes",
"code": {
"@type": "MedicalCode",
"code": "D015231",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.531.937.281"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladies sexuellement transmissibles virales",
"alternateName": "Sexually Transmitted Diseases, Viral",
"url": "https://questionsmedicales.fr/mesh/D015229",
"about": {
"@type": "MedicalCondition",
"name": "Maladies sexuellement transmissibles virales",
"code": {
"@type": "MedicalCode",
"code": "D015229",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.531.937.640"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Infections à papillomavirus",
"alternateName": "Papillomavirus Infections",
"url": "https://questionsmedicales.fr/mesh/D030361",
"about": {
"@type": "MedicalCondition",
"name": "Infections à papillomavirus",
"code": {
"@type": "MedicalCode",
"code": "D030361",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.531.937.640.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Infections à papillomavirus",
"alternateName": "Papillomavirus Infections",
"url": "https://questionsmedicales.fr/mesh/D030361",
"about": {
"@type": "MedicalCondition",
"name": "Infections à papillomavirus",
"code": {
"@type": "MedicalCode",
"code": "D030361",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.291.531.937.640.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Maladies transmissibles",
"alternateName": "Communicable Diseases",
"code": {
"@type": "MedicalCode",
"code": "D003141",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jeanette E Ward",
"url": "https://questionsmedicales.fr/author/Jeanette%20E%20Ward",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Sanjay Kalra",
"url": "https://questionsmedicales.fr/author/Sanjay%20Kalra",
"affiliation": {
"@type": "Organization",
"name": "Department of Endocrinology, Bharti Hospital, Karnal, India."
}
},
{
"@type": "Person",
"name": "Madhur Verma",
"url": "https://questionsmedicales.fr/author/Madhur%20Verma",
"affiliation": {
"@type": "Organization",
"name": "Department of Family and Community Medicine, AIIMS, Bathinda."
}
},
{
"@type": "Person",
"name": "Nitin Kapoor",
"url": "https://questionsmedicales.fr/author/Nitin%20Kapoor",
"affiliation": {
"@type": "Organization",
"name": "Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India; Non communicable disease unit, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia."
}
},
{
"@type": "Person",
"name": "Ib C Bygbjerg",
"url": "https://questionsmedicales.fr/author/Ib%20C%20Bygbjerg",
"affiliation": {
"@type": "Organization",
"name": "Global Health Section, Department of Public Health, University of Copenhagen, CSS, building 9, Copenhagen K, Denmark."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of migrants on communicable diseases in Thailand.",
"datePublished": "2024-07-29",
"url": "https://questionsmedicales.fr/article/39075400",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-024-19503-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Engagement of private health sector in communicable disease and immunization programmes in Pakistan.",
"datePublished": "2024-01-21",
"url": "https://questionsmedicales.fr/article/38415335",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.26719/emhj.24.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vaccination for communicable endemic diseases: optimal allocation of initial and booster vaccine doses.",
"datePublished": "2024-06-26",
"url": "https://questionsmedicales.fr/article/38926228",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00285-024-02111-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Province clustering based on the percentage of communicable disease using the BCBimax biclustering algorithm.",
"datePublished": "2023-09-12",
"url": "https://questionsmedicales.fr/article/37698368",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4081/gh.2023.1202"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis of the burden and trends of communicable diseases in Pacific Island countries from 1990 to 2019.",
"datePublished": "2023-10-21",
"url": "https://questionsmedicales.fr/article/37865756",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-023-16894-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Caractéristiques de la maladie",
"item": "https://questionsmedicales.fr/mesh/D020969"
},
{
"@type": "ListItem",
"position": 5,
"name": "Maladies transmissibles",
"item": "https://questionsmedicales.fr/mesh/D003141"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladies transmissibles - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladies transmissibles",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladies transmissibles",
"description": "Comment diagnostiquer une grippe ?\nQuels tests pour le VIH ?\nComment détecter la tuberculose ?\nQuels examens pour l'hépatite ?\nComment diagnostiquer la COVID-19 ?",
"url": "https://questionsmedicales.fr/mesh/D003141#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladies transmissibles",
"description": "Quels sont les symptômes de la rougeole ?\nQuels signes de la varicelle ?\nQuels symptômes du paludisme ?\nQuels signes de la tuberculose ?\nQuels symptômes de la grippe ?",
"url": "https://questionsmedicales.fr/mesh/D003141#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladies transmissibles",
"description": "Comment prévenir la grippe ?\nQuelles mesures pour éviter le VIH ?\nComment prévenir la tuberculose ?\nQuelles précautions pour la varicelle ?\nComment éviter la transmission de la COVID-19 ?",
"url": "https://questionsmedicales.fr/mesh/D003141#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladies transmissibles",
"description": "Quel traitement pour la tuberculose ?\nComment traiter le VIH ?\nQuel traitement pour la grippe ?\nComment traiter l'hépatite C ?\nQuel traitement pour la COVID-19 ?",
"url": "https://questionsmedicales.fr/mesh/D003141#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladies transmissibles",
"description": "Quelles complications de la grippe ?\nQuelles complications du VIH ?\nQuelles complications de la tuberculose ?\nQuelles complications de l'hépatite ?\nQuelles complications de la COVID-19 ?",
"url": "https://questionsmedicales.fr/mesh/D003141#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladies transmissibles",
"description": "Quels facteurs de risque pour le VIH ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour la grippe ?\nQuels facteurs de risque pour l'hépatite ?\nQuels facteurs de risque pour la COVID-19 ?",
"url": "https://questionsmedicales.fr/mesh/D003141#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une grippe ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests PCR ou des tests rapides d'antigènes."
}
},
{
"@type": "Question",
"name": "Quels tests pour le VIH ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins comme le test ELISA ou le test de charge virale sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment détecter la tuberculose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tuberculose se diagnostique par un test cutané ou une radiographie pulmonaire."
}
},
{
"@type": "Question",
"name": "Quels examens pour l'hépatite ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins pour détecter les anticorps et les antigènes du virus sont effectués."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer la COVID-19 ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par un test PCR ou un test antigénique nasal."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la rougeole ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, éruption cutanée, toux et écoulement nasal."
}
},
{
"@type": "Question",
"name": "Quels signes de la varicelle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La varicelle se manifeste par des démangeaisons et des vésicules sur la peau."
}
},
{
"@type": "Question",
"name": "Quels symptômes du paludisme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, sueurs, fatigue et douleurs musculaires sont fréquents."
}
},
{
"@type": "Question",
"name": "Quels signes de la tuberculose ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Toux persistante, perte de poids, fièvre et sueurs nocturnes sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la grippe ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, courbatures, fatigue, toux et maux de tête sont typiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir la grippe ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination annuelle et le lavage des mains sont essentiels pour prévenir la grippe."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter le VIH ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs et se faire dépister régulièrement sont des mesures clés."
}
},
{
"@type": "Question",
"name": "Comment prévenir la tuberculose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination BCG et le dépistage des cas contacts aident à prévenir la tuberculose."
}
},
{
"@type": "Question",
"name": "Quelles précautions pour la varicelle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination et l'isolement des cas sont des mesures préventives efficaces."
}
},
{
"@type": "Question",
"name": "Comment éviter la transmission de la COVID-19 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le port du masque, la distanciation sociale et la vaccination sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la tuberculose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des antibiotiques sur une période de 6 à 9 mois."
}
},
{
"@type": "Question",
"name": "Comment traiter le VIH ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH se traite par des antirétroviraux pour contrôler la charge virale."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la grippe ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux comme l'oseltamivir peuvent réduire la durée des symptômes."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hépatite C ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux à action directe sont utilisés pour guérir l'hépatite C."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la COVID-19 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des antiviraux et des soins de soutien selon la gravité."
}
},
{
"@type": "Question",
"name": "Quelles complications de la grippe ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des pneumonies, des bronchites et des exacerbations d'asthme peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quelles complications du VIH ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH peut entraîner des infections opportunistes et des cancers associés."
}
},
{
"@type": "Question",
"name": "Quelles complications de la tuberculose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tuberculose peut causer des lésions pulmonaires et des complications systémiques."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'hépatite ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hépatite peut entraîner une cirrhose et un cancer du foie à long terme."
}
},
{
"@type": "Question",
"name": "Quelles complications de la COVID-19 ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications respiratoires, cardiovasculaires et neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le VIH ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les rapports non protégés, le partage de seringues et l'absence de dépistage augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la tuberculose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "La malnutrition, le VIH et le surpeuplement sont des facteurs de risque majeurs."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la grippe ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées, les jeunes enfants et les immunodéprimés sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour l'hépatite ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le partage de matériel d'injection et les rapports sexuels non protégés augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la COVID-19 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies chroniques et l'obésité sont des facteurs de risque importants."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/07/2026
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
4 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Bharti Hospital, Karnal, India.
Publications dans "Maladies transmissibles" :
2 publications dans cette catégorie
Affiliations :
Department of Family and Community Medicine, AIIMS, Bathinda.
Publications dans "Maladies transmissibles" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India; Non communicable disease unit, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Publications dans "Maladies transmissibles" :
2 publications dans cette catégorie
Affiliations :
Global Health Section, Department of Public Health, University of Copenhagen, CSS, building 9, Copenhagen K, Denmark.
Publications dans "Maladies transmissibles" :
2 publications dans cette catégorie
Affiliations :
Graduate Program in Biological Sciences - Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro (RJ), Brazil.
Publications dans "Maladies transmissibles" :
2 publications dans cette catégorie
Affiliations :
Graduate Program in Biological Sciences - Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro (RJ), Brazil. dmafra30@gmail.com.
Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Niterói, RJ, Brazil. dmafra30@gmail.com.
Unidade de Pesquisa Clínica-UPC. Rua Marquês de Paraná, Niterói-RJ, 303/4 Andar , Niterói, RJ, 24033-900, Brazil. dmafra30@gmail.com.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
Department of Community Medicine, Shaheed Hassan Khan Mewati Government Medical College, Nalhar, Mewat, India.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
GIBEC Research Group. Life Sciences Faculty. Universidad EIA, Calle 25 Sur # 42-73, Medellín, Colombia. Electronic address: kaory.barrientos@eia.edu.co.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
GIBEC Research Group. Life Sciences Faculty. Universidad EIA, Calle 25 Sur # 42-73, Medellín, Colombia.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
GIBEC Research Group. Life Sciences Faculty. Universidad EIA, Calle 25 Sur # 42-73, Medellín, Colombia.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
Institute of Life Science, Swansea University Medical School, Singleton Park, Swansea SA2 8PP, UK; VEDAS Corporación de Investigación e Innovación (VEDAS CII), Cl 8 B 65-261 050024, 7 Medellín, Colombia.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
GIBEC Research Group. Life Sciences Faculty. Universidad EIA, Calle 25 Sur # 42-73, Medellín, Colombia.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
GIBEC Research Group. Life Sciences Faculty. Universidad EIA, Calle 25 Sur # 42-73, Medellín, Colombia.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
GIBEC Research Group. Life Sciences Faculty. Universidad EIA, Calle 25 Sur # 42-73, Medellín, Colombia.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
GIBEC Research Group. Life Sciences Faculty. Universidad EIA, Calle 25 Sur # 42-73, Medellín, Colombia.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
Institute of Life Science, Swansea University Medical School, Singleton Park, Swansea SA2 8PP, UK; Department of Physics, Centre for NanoHealth, Swansea University, Swansea SA2 8PP, Wales, UK; VEDAS Corporación de Investigación e Innovación (VEDAS CII), Cl 8 B 65-261 050024, 7 Medellín, Colombia.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
GIBEC Research Group. Life Sciences Faculty. Universidad EIA, Calle 25 Sur # 42-73, Medellín, Colombia.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
GIBEC Research Group. Life Sciences Faculty. Universidad EIA, Calle 25 Sur # 42-73, Medellín, Colombia.
Publications dans "Maladies transmissibles" :
1 publication dans cette catégorie
Affiliations :
Esperer Onco Nutrition Pvt. Ltd., Mumbai, India.
Department of Biological Sciences, Birla Institute of Technology and Science - Pilani, Hyderabad, India.
Publications dans "Maladies transmissibles" :
While foreign migrants contribute to economic development, they may impact public health by transmitting communicable diseases to the local population. With its geopolitical position, Thailand has bee...
A spatial panel autoregressive model (SAR) is applied on the provincial level communicable diseases and socio-economic data in Thailand from the period 2016 to 2021....
The results indicate that the influence of foreign migrants on communicable diseases in Thailand varies depending on the type of disease. While an increase in migrants correlates with a higher prevale...
As revealed by this study, the increase in migrants leads to a rise in respiratory and other communicable diseases, as well as a decrease in vaccine-preventable diseases, which carries significant pol...
In Pakistan, where the burden of communicable diseases remains high, the private sector accounts for 62% of health care provision....
To describe the role of the private sector in communicable disease management in Pakistan and inform a more effective engagement towards achieving Universal Health Coverage....
We searched the literature and available documents on policies, regulations and experiences in private health sector engagement in Pakistan. We interviewed policy level experts regarding the formulati...
Published reports described initiatives to engage the private sector in improving coverage for a package of care and programme-specific initiatives. Pakistan did not have a national policy for structu...
We recommend that the Ministry of Health provide overall vision for the operations of the public and private health sectors so that both sectors can complement each other towards the achievement of Un...
For some communicable endemic diseases (e.g., influenza, COVID-19), vaccination is an effective means of preventing the spread of infection and reducing mortality, but must be augmented over time with...
Indonesia needs to lower its high infectious disease rate. This requires reliable data and following their temporal changes across provinces. We investigated the benefits of surveying the epidemiologi...
Communicable diseases contribute substantially to morbidity and death rates worldwide, particularly in low-and middle-income countries. Pacific Island countries face unique challenges in addressing th...
This study aimed to analyze the burden and trends of communicable diseases in Pacific Island countries from 1990 to 2019....
We utilized data from the 2019 Global Burden of Disease (GBD) study to analyze indicators including incidence, death, and disability-adjusted life years (DALYs). Excel 2016, R 4.2.1, and GraphPad Pris...
From 1990 to 2019, the standardized incidence rate of communicable diseases in Pacific Island countries showed an upward trend (AAPC = 0.198%, 95% CI = 0.0174 ~ 0.221), while the standardized death ra...
The burden of communicable diseases in Pacific Island countries remains high, despite improvements in mortality and disability-adjusted life-year rates over the past few decades. This study provides v...
The concurrent occurrence of infectious diseases (IDs) and non-communicable diseases (NCDs) presents complex healthcare challenges in sub-Saharan Africa (SSA), where healthcare systems often grapple w...
Based on the Joanna Briggs Institute (JBI) framework for scoping reviews, this study will include peer-reviewed and grey literature reporting on integrated care models for NCD-ID comorbidities in SSA....
Ethical approval is not required for this review as it will synthesise published data and does not involve human participants. The final report will be submitted for publication in a peer-reviewed jou...
OSF: https://doi.org/10.17605/OSF.IO/KFVEY....
Communicable disease risk is high in refugee camps and reception centers. To better understand the risks for communicable disease diagnoses among refugees and asylum seekers, this study assesses indiv...
Staff at public health departments have few training materials to learn how to design and fine-tune systems to quickly detect acute, localized, community-acquired outbreaks of infectious diseases. Sin...
Viruses can cause many human diseases. Three types of human diseases caused by viruses are discussed in this chapter: infectious diseases, autoimmune diseases, and cancers. The infectious diseases inc...
As the volume and complexity of solid organ and hematopoietic stem cell transplantation continue to see rapid growth, the training of a specialized transplant infectious diseases physician workforce i...
Despite the first publication of a transplant infectious diseases curriculum in 2010, more recent surveys of infectious diseases trainees have identified gaps in didactic curriculum, donor and recipie...
This review of transplant infectious diseases training summarizes growth through the decades, the current landscape of recommend training elements, suggested areas for continued development and expans...